[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 49, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 570781, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 367467, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 60, "title": "Co-Founder, Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.865, "open": 3.94, "dayLow": 3.75, "dayHigh": 3.9662, "regularMarketPreviousClose": 3.865, "regularMarketOpen": 3.94, "regularMarketDayLow": 3.75, "regularMarketDayHigh": 3.9662, "payoutRatio": 0.0, "beta": -0.888, "forwardPE": -0.5225718, "volume": 107202, "regularMarketVolume": 107202, "averageVolume": 103246, "averageVolume10days": 147570, "averageDailyVolume10Day": 147570, "bid": 3.78, "ask": 3.92, "bidSize": 1, "askSize": 1, "marketCap": 16218612, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.0116, "twoHundredDayAverage": 4.721195, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8300514, "profitMargins": 0.0, "floatShares": 3759318, "sharesOutstanding": 4245710, "sharesShort": 171551, "sharesShortPriorMonth": 92894, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.045500003, "heldPercentInsiders": 0.025829999, "heldPercentInstitutions": 0.02311, "shortRatio": 2.01, "shortPercentOfFloat": 0.0469, "impliedSharesOutstanding": 4245710, "bookValue": 2.191, "priceToBook": 1.7434961, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15545737, "trailingEps": -4.03, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.554, "52WeekChange": -0.5922996, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 3.82, "targetHighPrice": 60.0, "targetLowPrice": 8.0, "targetMeanPrice": 29.0, "targetMedianPrice": 20.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 12211321, "totalCashPerShare": 3.24, "ebitda": -14991883, "totalDebt": 5099079, "quickRatio": 2.462, "currentRatio": 2.546, "debtToEquity": 68.393, "returnOnAssets": -1.06539, "returnOnEquity": -53.05024, "grossProfits": -9445265, "freeCashflow": -12844647, "operatingCashflow": -18451388, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1747438879, "regularMarketTime": 1747425601, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "postMarketChangePercent": 2.35602, "postMarketPrice": 3.91, "postMarketChange": 0.0900002, "regularMarketChange": -0.045000076, "regularMarketDayRange": "3.75 - 3.9662", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 103246, "fiftyTwoWeekLowChange": 2.02, "fiftyTwoWeekLowChangePercent": 1.1222222, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -17.01, "fiftyTwoWeekHighChangePercent": -0.8166107, "fiftyTwoWeekChangePercent": -59.229958, "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "regularMarketChangePercent": -1.1642969, "regularMarketPrice": 3.82, "marketState": "CLOSED", "epsTrailingTwelveMonths": -4.03, "epsForward": -7.31, "epsCurrentYear": -2.48, "priceEpsCurrentYear": -1.5403225, "fiftyDayAverageChange": -0.19160008, "fiftyDayAverageChangePercent": -0.04776151, "twoHundredDayAverageChange": -0.9011953, "twoHundredDayAverageChangePercent": -0.19088286, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]